🇫🇷 France Country × Condition
pulmonary embolism Clinical Trials in France
Active clinical trials for pulmonary embolism with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇫🇷 France
Active Trials in France (5)
NCT05103670
Recruiting
Ventilation/Perfusion PET/CT With Galligas and 68Ga-MAA for Regional Lung Function Assessment After Pulmonary Embolism
Enrollment
32 pts
Country
🇫🇷 France
University Hospital, Brest
View Trial → NCT06480994
Recruiting
Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support
Enrollment
1,836 pts
Country
🇫🇷 France
Diagnostica Stago R&D
View Trial → NCT06372730
Recruiting
Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT)
Enrollment
665 pts
Country
🇫🇷 France
University Hospital, Brest
View Trial → NCT06588634
Recruiting
The PERSEVERE Study
Enrollment
200 pts
Country
🇫🇷 France
Inari Medical
View Trial → NCT05015153
Recruiting
Impact on Quality of Life With Pulmonary RehAbilitation After Pulmonary eMBOlism: RAMBO Study
Enrollment
112 pts
Country
🇫🇷 France
University Hospital, Brest
View Trial → Frequently Asked Questions
How many pulmonary embolism clinical trials are active in France?
There are currently 5 active clinical trials for pulmonary embolism with sites in France, of which 5 are actively recruiting patients.
How can I join a pulmonary embolism clinical trial in France?
To join a pulmonary embolism clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are pulmonary embolism trials in France?
Active pulmonary embolism trials in France span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology